2m 2m 2m 2m 2m 2m 2m
ERASCA (ERAS)
NASDAQ
$15.02-$0.06 (-0.43%)
Price as of Jun 23, 2026 7:43 PM EDT- $4.7BMarket Cap
- 984.89%1-Year Change
- BiotechnologyIndustry
ERASCA (ERAS)
$15.02-$0.06 (-0.43%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -92.9M -19.51% | -115.4M +11.11% | -103.8M -51.59% | -214.5M +152.99% | |
Depreciation and Amortization Expense | 3.1M -18.34% | 3.8M +1.96% | 3.7M +41.31% | 2.6M +218.58% | |
Total Operating Expenses | 140.9M -21.54% | 179.6M +26.89% | 141.5M -42.81% | 247.4M +98.15% | |
Operating Profit | -140.9M -21.54% | -179.6M +26.89% | -141.5M -42.81% | -247.4M +98.15% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | 16.4M -8.80% | 17.9M +8.82% | 16.5M +254.85% | 4.6M +119.21% | |
Income before Taxes | -140.9M -21.54% | -179.6M +26.89% | -141.5M -42.81% | -247.4M +98.15% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -124.5M -22.95% | -161.7M +29.28% | -125.0M -48.50% | -242.8M +97.78% | |
Net Income from Continuing Operations Applicable to Common | -124.5M -22.95% | -161.7M +29.28% | -125.0M -48.50% | -242.8M +97.78% | |
Basic EPS and Net Income | -0.44 -36.23% | -0.69 -16.87% | -0.83 -58.29% | -1.99 +7.57% | |
Diluted EPS and Net Income | -0.44 -36.23% | -0.69 -16.87% | -0.83 -58.29% | -1.99 +7.57% | |
Basic Weighted Average Shares | 283.5M +21.26% | 233.8M +55.69% | 150.2M +23.08% | 122.0M +84.08% | |
Diluted Weighted Average Shares | 283.5M +21.26% | 233.8M +55.69% | 150.2M +23.08% | 122.0M +84.08% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 73.8M +8.95% | 67.7M -27.22% | 93.1M -67.25% | 284.2M -21.16% | |
Short-Term Investments | 202.3M -12.27% | 230.6M +5.15% | 219.3M +44.83% | 151.4M +180.44% | |
Cash and Cash Equivalents and Short-Term Investments | 276.1M -7.45% | 298.3M -4.50% | 312.4M -28.30% | 435.6M +5.10% | |
Total Current Assets | 286.2M -7.30% | 308.8M -3.71% | 320.7M -27.86% | 444.5M +5.83% | |
Accumulated Depreciation | 12.7M +26.50% | 10.0M +38.40% | 7.2M +106.63% | 3.5M +102.66% | |
Property and Plant and Equipment and Net | 13.3M -18.49% | 16.3M -26.90% | 22.3M -10.03% | 24.8M +55.54% | |
Total Long-Term Assets | 1.5M -44.58% | 2.6M -40.18% | 4.4M -8.15% | 4.8M +63.99% | |
Total Assets | 396.2M -21.17% | 502.5M +27.13% | 395.3M -23.23% | 514.9M +2.69% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 28.5M -9.19% | 31.4M +20.03% | 26.2M -46.28% | 48.7M +84.56% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 399,000 +10.22% | 362,000 -36.04% | 566,000 -1.22% | 573,000 -96.90% | |
Total Liabilities | 71.0M -10.18% | 79.0M +0.53% | 78.6M -23.72% | 103.1M +129.59% | |
Retained Earnings | -892.2M +16.22% | -767.7M +26.67% | -606.0M +26.00% | -481.0M +101.95% | |
Total Stockholders Equity | 325.2M -23.22% | 423.5M +33.73% | 316.7M -23.11% | 411.9M -9.79% | |
Total Shares Outstanding | 284.2M +0.33% | 283.2M +87.45% | 151.1M +1.18% | 149.3M +25.38% | |
Cash Flow | |||||
Cash from Operating Activities | -95.5M -12.76% | -109.4M +8.10% | -101.2M -1.98% | -103.3M +29.73% | |
Capital Expenditures | 128,000 +113.33% | 60,000 -96.62% | 1.8M -87.80% | 14.6M +29.86% | |
Cash from Investing Activities | 100.4M +164.12% | -156.6M +71.69% | -91.2M +28.33% | -71.1M +10.05% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 1.1M -99.54% | 240.7M +18,486.64% | 1.3M -98.68% | 98.1M -77.68% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Return on Assets | -27.72% -23.03% | -36.01% +31.06% | -27.48% -42.50% | -47.78% N/A | |
Return on Equity | -33.27% -23.83% | -43.68% +27.24% | -34.33% -38.62% | -55.92% N/A | |
Revenue Growth | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Current Ratio | 10.04 +2.07% | 9.84 -19.77% | 12.26 +34.30% | 9.13 N/A | |
Cash Ratio | 2.59 +19.98% | 2.16 -39.37% | 3.56 -39.04% | 5.84 N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow